Pittsburgh area clinic owner accused of giving weight-loss patients cow drugs

The U.S Attorney’s Office has charged a Pittsburgh area wellness counselor with mislabeling medication meant for cows and giving it to her weight-loss patients. Nicole Millen is not a licensed medical professional. Authorities say she operated two weight loss clinics in the Pittsburgh area: Renu Medical and Weight Loss and Choice Restorative Medicine.Court documents allege that between February of 2022 and May of 2023, Millen prescribed her patients the drug Chorulon. Chorulon is used is to treat cystic ovaries in cows and is not approved for human use. It does contain the same active ingredient as some drugs that are approved for human use. Investigators say Millen told her patients that’s what they were taking.Millen and her employees allegedly ordered the drug from a retailer in Illinois, mixed it with a dilutant, put it in unlabeled syringes, and gave it to customers.Investigators have not said how many people may have been impacted or if the Chorulon caused any medical complications.Court records indicate that Millen will waive arraignment and plead guilty to ‘causing a drug to be misbranded after shipment’ on Nov. 18.

SCOTT TOWNSHIP, Pa. —

The U.S Attorney’s Office has charged a Pittsburgh area wellness counselor with mislabeling medication meant for cows and giving it to her weight-loss patients.

Nicole Millen is not a licensed medical professional. Authorities say she operated two weight loss clinics in the Pittsburgh area: Renu Medical and Weight Loss and Choice Restorative Medicine.

Court documents allege that between February of 2022 and May of 2023, Millen prescribed her patients the drug Chorulon.

Chorulon is used is to treat cystic ovaries in cows and is not approved for human use.
It does contain the same active ingredient as some drugs that are approved for human use. Investigators say Millen told her patients that’s what they were taking.

Millen and her employees allegedly ordered the drug from a retailer in Illinois, mixed it with a dilutant, put it in unlabeled syringes, and gave it to customers.

Investigators have not said how many people may have been impacted or if the Chorulon caused any medical complications.

Court records indicate that Millen will waive arraignment and plead guilty to ‘causing a drug to be misbranded after shipment’ on Nov. 18.